StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) stock

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$5.90−0.40 (-6.35%)

Close on Nov 20, 2026Market cap $38.42MP/E –Yield –

Tevogen gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Tevogen

Tevogen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tevogen figures

See a number that looks wrong?